Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,477 public trials 2,002 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

NCT07029399

Conditions
Breast Diseases, Breast Neoplasms, CCNE1 Amplified Advanced Solid Tumors, +12 more
Locations
  • City of Hope Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid Tumors

NCT05461768

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Dongguan People's Hospital Dongguan, Guangdong, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangdong, Guangzhou, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

NCT06582017

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +54 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer Los Angeles, California, United States
  • Cedars-Sanai Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport, California, United States
View Trial Details
Recruiting

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

NCT07660055

Conditions
Bladder Cancer, Breast Cancer, Breast Diseases, +24 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details
Recruiting

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

NCT06726148

Conditions
Advanced CCNE1-amplified Solid Tumors, Advanced HR+/HER2- Breast Cancer, Breast Diseases, +14 more
Locations
  • University of California LA Los Angeles, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • WA Uni School Of Med St Louis, Missouri, United States
View all 33 locations
View Trial Details
Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

NCT06827236

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +6 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer & Blood Center, LLC Athens, Georgia, United States
View all 78 locations
View Trial Details

Related conditions